Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$331M |
| 2 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$324M |
| 3 |
Salesforce
CRM
|
+$301M |
| 4 |
Adobe
ADBE
|
+$294M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$422M |
| 2 |
Lloyds Banking Group
LYG
|
+$252M |
| 3 |
Barclays
BCS
|
+$135M |
| 4 |
FIYY
Barclays ETN+ FI Enhanced Global High Yield ETN Series B
FIYY
|
+$72M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$62.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 12.53% |
| 4 | Consumer Discretionary | 8% |
| 5 | Consumer Staples | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Travere Therapeutics
TVTX
$5.2B
| $1.13M | ﹤0.01% |
49,960
+30
| +0.1% | +$746 |
|
527
CVS Health
CVS
$133B
| $1.12M | ﹤0.01% |
17,111
+62
| +0.4% | +$4.63K |
|
528
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $1.11M | ﹤0.01% |
35,802
+19,508
| +120% | +$660K |
|
529
iShares Global Financials ETF
IXG
$678M
| $1.11M | ﹤0.01% |
19,490
| – | – |
|
|
CLVS
530
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.07M | ﹤0.01% |
59,431
| – | – |
|
531
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $1.06M | ﹤0.01% |
20,618
-10,705
| -34% | -$552K |
|
532
Lennar Class B
LEN.B
$19.4B
| $1.06M | ﹤0.01% |
35,486
-4
| -0% | -$132 |
|
|
533
Lloyds Banking Group
LYG
$89.5B
| $1.04M | ﹤0.01% |
406,364
-88,598,071
| -100% | -$252M |
|
534
DuPont de Nemours
DD
$18.5B
| $1.04M | ﹤0.01% |
7,671
+521
| +7% | +$74.8K |
|
535
Lantheus
LNTH
$6.49B
| $1.04M | ﹤0.01% |
66,274
-374
| -0.6% | -$5.73K |
|
536
Trane Technologies
TT
$100B
| $1.04M | ﹤0.01% |
11,364
-748
| -6% | -$73.5K |
|
|
ADMS
537
DELISTED
Adamas Pharmaceuticals
ADMS
| $1.04M | ﹤0.01% |
121,459
+3,342
| +3% | +$43.5K |
|
538
Northern Oil and Gas
NOG
$2.3B
| $1.01M | ﹤0.01% |
44,727
-5,015
| -10% | -$147K |
|
539
iShares Core MSCI EAFE ETF
IEFA
$190B
| $993K | ﹤0.01% |
18,050
+83
| +0.5% | +$4.87K |
|
540
State Street SPDR Portfolio Mortgage Backed Bond ETF
SPMB
$6.95B
| $992K | ﹤0.01% |
39,050
+3,590
| +10% | +$89.9K |
|
|
LABL
541
DELISTED
Multi-Color Corp
LABL
| $960K | ﹤0.01% |
27,359
-250
| -0.9% | -$11.8K |
|
|
BAY
542
DELISTED
BAYER AG SPONS ADR
BAY
| $960K | ﹤0.01% |
55,477
-764,228
| -93% | -$13.2M |
|
543
Norfolk Southern
NSC
$75.4B
| $928K | ﹤0.01% |
6,207
+997
| +19% | +$164K |
|
|
544
Barclays
BCS
$92.7B
| $895K | ﹤0.01% |
124,098
-16,793,464
| -99% | -$135M |
|
545
Enanta Pharmaceuticals
ENTA
$366M
| $865K | ﹤0.01% |
12,214
| – | – |
|
546
Shinhan Financial Group
SHG
$32.8B
| $852K | ﹤0.01% |
24,000
-12,300
| -34% | -$464K |
|
547
W&T Offshore
WTI
$534M
| $843K | ﹤0.01% |
204,657
| – | – |
|
548
Lockheed Martin
LMT
$134B
| $819K | ﹤0.01% |
3,128
-888
| -22% | -$269K |
|
|
AGN
549
DELISTED
Allergan plc
AGN
| $815K | ﹤0.01% |
6,097
-32
| -0.5% | -$5.25K |
|
|
MNTA
550
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $814K | ﹤0.01% |
73,701
+8,176
| +12% | +$114K |
|
Similar funds
Ken Fisher's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Fisher held 954 positions worth $73.2B, down 11% from $82.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Ken Fisher deployed $3.18B of net new capital in Q4 2018, opening 84 new positions and adding to 428 existing holdings. Its largest new stake was Weibo: 2,764,345 shares worth $162M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vodafone, an estimated $422M trimmed.
- Ken Fisher's largest Q4 2018 buy was Weibo: 2,764,345 shares worth $162M.
- Ken Fisher added most to Cisco in Q4 2018, an estimated $331M increase.
- Ken Fisher's biggest Q4 2018 reduction was Vodafone, cutting an estimated $422M.
- Ken Fisher fully exited Luxottica Group in Q4 2018, selling an estimated $51M.
- Ken Fisher's ten largest holdings make up 26% of its $73.2B portfolio in Q4 2018.
- Ken Fisher opened 84 new positions and closed 88 in Q4 2018.
- Ken Fisher's portfolio value fell 11% quarter-over-quarter to $73.2B.
Based on Fisher Asset Management's 13F filing for Q4 2018, filed 25 Jan 2019.